US Oncology Financial Analyst Salaries in Boulder | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Financial Analyst Salaries in Boulder

The average US Oncology Financial Analyst in Boulder earns an estimated $76,879 annually, which includes an estimated base salary of $70,546 with a $6,333 bonus. US Oncology's Financial Analyst compensation is $10,521 less than the US average for a Financial Analyst. Financial Analyst salaries at US Oncology in Boulder can range from $57,500 - $86,000.

In Boulder, The Finance Department at US Oncology earns $6,646 more on average than the Operations Department.

Last updated 7 months ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$76,879
Average Compensation
$70,546
avg. base
$6,333
avg. bonus

Financial Analyst Salaries at US Oncology

In Boulder, Financial Analysts earn $3,120 more than Financial Analysts, and $2,732 less than Business Analysts.

Accounting Manager
$98k*
Senior Accountant
$92k*
Business Analyst
$80k*
Financial Analyst
$74k*
Accountant
$71k*
* estimated salary

Compensation at US Oncology by Department

In Boulder, The Finance Department averages $6,646 more than the Operations Department, and $14,071 less than the Sales Department

Sales
$91,161 Avg. total comp.
+$14k
Finance
$77,090 Avg. total comp.
Operations
$70,444 Avg. total comp.
-$7k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to US Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to US Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at US Oncology Rate Their Compensation

The majority of Financial Analysts at US Oncology believe they're compensated fairly. 50% of Financial Analysts at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company